A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.


Updates from The Motley Fool

Latest updates on Theravance from Fool.com.


Stock Performance

THRX vs. S&P 500 | 2 Year Performance
View Interactive THRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Theravance.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0.00
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $1.00 (10.2%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rick E. Winningham, CEO

80% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Theravance.

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers